178 related articles for article (PubMed ID: 1813069)
1. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
[TBL] [Abstract][Full Text] [Related]
2. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
Horwitz KB; Freidenberg GR
Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
[TBL] [Abstract][Full Text] [Related]
5. Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.
Poulin R; Dufour JM; Labrie F
Breast Cancer Res Treat; 1989 Jul; 13(3):265-76. PubMed ID: 2667655
[TBL] [Abstract][Full Text] [Related]
6. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line.
Hurd C; Khattree N; Alban P; Nag K; Jhanwar SC; Dinda S; Moudgil VK
J Biol Chem; 1995 Dec; 270(48):28507-10. PubMed ID: 7499360
[TBL] [Abstract][Full Text] [Related]
7. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F
Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395
[TBL] [Abstract][Full Text] [Related]
9. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
10. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.
Sarup JC; Rao KV; Fox CF
Cancer Res; 1988 Sep; 48(18):5071-8. PubMed ID: 3044580
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
[TBL] [Abstract][Full Text] [Related]
12. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells.
Papa V; Reese CC; Brunetti A; Vigneri R; Siiteri PK; Goldfine ID
Cancer Res; 1990 Dec; 50(24):7858-62. PubMed ID: 2253226
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth.
Sampath D; Winneker RC; Zhang Z
Endocrine; 2002 Jul; 18(2):147-59. PubMed ID: 12374462
[TBL] [Abstract][Full Text] [Related]
14. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D.
Hissom JR; Bowden RT; Moore MR
Endocrinology; 1989 Jul; 125(1):418-23. PubMed ID: 2737155
[TBL] [Abstract][Full Text] [Related]
15. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Castronovo V; Taraboletti G; Liotta LA; Sobel ME
J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
[TBL] [Abstract][Full Text] [Related]
16. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).
Chalbos D; Vignon F; Keydar I; Rochefort H
J Clin Endocrinol Metab; 1982 Aug; 55(2):276-83. PubMed ID: 7045150
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
[TBL] [Abstract][Full Text] [Related]
18. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells.
van den Brûle FA; Engel J; Stetler-Stevenson WG; Liu FT; Sobel ME; Castronovo V
Int J Cancer; 1992 Oct; 52(4):653-7. PubMed ID: 1399148
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Murphy CS; Pink JJ; Jordan VC
Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
[TBL] [Abstract][Full Text] [Related]
20. Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II.
Papa V; Hartmann KK; Rosenthal SM; Maddux BA; Siiteri PK; Goldfine ID
Mol Endocrinol; 1991 May; 5(5):709-17. PubMed ID: 1649393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
